The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences GILD.O lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents at high risk of ...

On World TB Day in March 2024, the he­­alth ministry announced grim statistics: newly notified cases increased from 11,050 in ...

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

Gilead said the price is comparable to existing HIV prevention drugs and the company will work with insurers to obtain broad coverage of the drug. Advocates say the long-acting medication ...

"This really has the possibility of ending HIV transmission," said Greg Millett, public policy director at The Foundation for ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

The story of the AIDS movement is one of regular people: students, bartenders, stay-at-home mothers, teachers, retired lawyers, immigrants, Catholic nuns, newly out gay men who had just arrived in New ...

Some had lost friends or lovers. Some felt a moral calling. Some were just trying to balance their sexual karma. Many were angry. Most had no medical background or professional credentials – just a ...

Without US funding as leverage, one of Uganda’s most prominent LGBT+ activists Steven Kabuye tells Rachel Schraer, there are ...

Meghalaya is now ranked sixth among the highest HIV prevalence states in India, State Health and Family Welfare Minister, ...